MedTrace Logo

Obesity, Inflammation and Oxidative Stress

NCT01028976 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 512

Last updated 2015-12-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether or not Vitamin C (1000 mg/day) can reduce markers of inflammation, especially C-reactive protein (CRP), in obese persons with baseline CRP greater than 1 mg/dl.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin C (ascorbic acid)

1000 mg/day (two 500-mg tablets), 8 weeks

DIETARY_SUPPLEMENT

Placebo tablet

Placebo tablet (two 500-mg tablets), 8 weeks

Sponsors & Collaborators

Principal Investigators

  • Gladys Block, PhD · University of California, Berkeley

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01028976 on ClinicalTrials.gov